| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.29 | 0.3 |